Jackson Creek Investment Advisors’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-32,432	Closed	-$1.02M	–	295
2023 Q4	$1.02M	Buy	32,432 +1	+0%	+$31	0.39%	105
2023 Q3	$676K	Sell	32,431 -14,964	-32%	-$312K	0.29%	189
2023 Q2	$1.14M	Buy	47,395 +2,959	+7%	+$70.9K	0.45%	42
2023 Q1	$836K	Buy	+44,436	New	+$836K	0.35%	145